Article
13 Mar 2026
Market Exclusivity and Data Exclusivity included in Drug Administration Law revisions
AUTHORS CONTENT
Article
26 Nov 2025
Amendments to patent examination guidelines finalised
Article
19 Nov 2025
Patent rules changed for dual filing, abandon utility model for grant of invention patent
Article
07 Sep 2025
Draft changes to dual filing in China
Article
31 Aug 2025
How Divisional Patent Applications Work In China
Article
03 Jun 2025
Establishing inventive step in Swiss-type use claims – A case study on disease subtypes and known APIs.
Article
17 May 2025
New trends for patent examination? Draft Amendments to the Guidelines of Patent Examination
Article
04 May 2025
Good Faith Principle For Patent Applications
Article
11 Mar 2025
Recent updates on post-filing data for patent applications
Article
24 Feb 2025
Patent examination shift for siRNA drugs in China
Article
06 Feb 2025
Post-filing data in addressing non-support issues
Article
26 Aug 2024
Pharmaceutical Patent disputes in China | The nuances of "offer to sell"
Article
29 May 2024
China joins Patent Prosecution Highway Improvement initiative
Article
13 Mar 2024
Patents and invalidation challenges - navigating translation accuracy
Article
10 Jan 2024
China issues new rules for implementing patent law and guidelines for examination
Article
27 Nov 2023
From Idea to Intellectual Property: Why breaking into the Chinese market is big business
Article
22 Nov 2023
Apostille Convention now in effect in China
Article
19 Jul 2023
Case study: A successful example of post-filing data to address the support issue under China patent practice
Article
15 Apr 2023
China National Intellectual Property Administration (CNIPA) improves efficiency and quality of patent examination
Article
13 Mar 2023
Patent examination and IP protection developments in PRC bring a more appealing environment for patentees and applicants
